616 related articles for article (PubMed ID: 28871520)
1. Visceral Adiposity and Sarcopenic Visceral Obesity are Associated with Poor Prognosis After Resection of Pancreatic Cancer.
Okumura S; Kaido T; Hamaguchi Y; Kobayashi A; Shirai H; Yao S; Yagi S; Kamo N; Hatano E; Okajima H; Takaori K; Uemoto S
Ann Surg Oncol; 2017 Nov; 24(12):3732-3740. PubMed ID: 28871520
[TBL] [Abstract][Full Text] [Related]
2. Impact of Visceral Adiposity as Well as Sarcopenic Factors on Outcomes in Patients Undergoing Liver Resection for Colorectal Liver Metastases.
Kobayashi A; Kaido T; Hamaguchi Y; Okumura S; Shirai H; Kamo N; Yagi S; Taura K; Okajima H; Uemoto S
World J Surg; 2018 Apr; 42(4):1180-1191. PubMed ID: 28936708
[TBL] [Abstract][Full Text] [Related]
3. Impact of Skeletal Muscle Mass, Muscle Quality, and Visceral Adiposity on Outcomes Following Resection of Intrahepatic Cholangiocarcinoma.
Okumura S; Kaido T; Hamaguchi Y; Kobayashi A; Shirai H; Fujimoto Y; Iida T; Yagi S; Taura K; Hatano E; Okajima H; Uemoto S
Ann Surg Oncol; 2017 Apr; 24(4):1037-1045. PubMed ID: 27837297
[TBL] [Abstract][Full Text] [Related]
4. Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinoma.
Fujiwara N; Nakagawa H; Kudo Y; Tateishi R; Taguri M; Watadani T; Nakagomi R; Kondo M; Nakatsuka T; Minami T; Sato M; Uchino K; Enooku K; Kondo Y; Asaoka Y; Tanaka Y; Ohtomo K; Shiina S; Koike K
J Hepatol; 2015 Jul; 63(1):131-40. PubMed ID: 25724366
[TBL] [Abstract][Full Text] [Related]
5. Impact of preoperative quality as well as quantity of skeletal muscle on survival after resection of pancreatic cancer.
Okumura S; Kaido T; Hamaguchi Y; Fujimoto Y; Masui T; Mizumoto M; Hammad A; Mori A; Takaori K; Uemoto S
Surgery; 2015 Jun; 157(6):1088-98. PubMed ID: 25799468
[TBL] [Abstract][Full Text] [Related]
6. Impact of sarcopenic obesity on outcomes in patients undergoing living donor liver transplantation.
Kamo N; Kaido T; Hamaguchi Y; Okumura S; Kobayashi A; Shirai H; Yao S; Yagi S; Uemoto S
Clin Nutr; 2019 Oct; 38(5):2202-2209. PubMed ID: 30482562
[TBL] [Abstract][Full Text] [Related]
7. Preoperative sarcopenia is associated with poor overall survival in pancreatic cancer patients following pancreaticoduodenectomy.
Peng YC; Wu CH; Tien YW; Lu TP; Wang YH; Chen BB
Eur Radiol; 2021 Apr; 31(4):2472-2481. PubMed ID: 32974690
[TBL] [Abstract][Full Text] [Related]
8. Impact of body composition parameters on clinical outcomes in patients with metastatic castrate-resistant prostate cancer treated with docetaxel.
Cushen SJ; Power DG; Murphy KP; McDermott R; Griffin BT; Lim M; Daly L; MacEneaney P; O' Sullivan K; Prado CM; Ryan AM
Clin Nutr ESPEN; 2016 Jun; 13():e39-e45. PubMed ID: 28531567
[TBL] [Abstract][Full Text] [Related]
9. Clinical impact of sarcopenia on prognosis in pancreatic ductal adenocarcinoma: A retrospective cohort study.
Ninomiya G; Fujii T; Yamada S; Yabusaki N; Suzuki K; Iwata N; Kanda M; Hayashi M; Tanaka C; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
Int J Surg; 2017 Mar; 39():45-51. PubMed ID: 28110029
[TBL] [Abstract][Full Text] [Related]
10. Sarcopenia as a Predictor of Survival in Patients with Pancreatic Adenocarcinoma After Pancreatectomy.
Rom H; Tamir S; Van Vugt JLA; Berger Y; Perl G; Morgenstern S; Tovar A; Brenner B; Benchimol D; Kashtan H; Sadot E
Ann Surg Oncol; 2022 Mar; 29(3):1553-1563. PubMed ID: 34716836
[TBL] [Abstract][Full Text] [Related]
11. A high visceral adipose tissue-to-skeletal muscle ratio as a determinant of major complications after pancreatoduodenectomy for cancer.
Sandini M; Bernasconi DP; Fior D; Molinelli M; Ippolito D; Nespoli L; Caccialanza R; Gianotti L
Nutrition; 2016; 32(11-12):1231-7. PubMed ID: 27261062
[TBL] [Abstract][Full Text] [Related]
12. Skeletal Muscle Depletion Predicts the Prognosis of Patients with Advanced Pancreatic Cancer Undergoing Palliative Chemotherapy, Independent of Body Mass Index.
Choi Y; Oh DY; Kim TY; Lee KH; Han SW; Im SA; Kim TY; Bang YJ
PLoS One; 2015; 10(10):e0139749. PubMed ID: 26437072
[TBL] [Abstract][Full Text] [Related]
13. High visceral fat attenuation and long-term mortality in a health check-up population.
Lee JH; Choi SH; Jung KJ; Goo JM; Yoon SH
J Cachexia Sarcopenia Muscle; 2023 Jun; 14(3):1495-1507. PubMed ID: 37016984
[TBL] [Abstract][Full Text] [Related]
14. Prognostic values of abdominal body compositions on survival in advanced pancreatic cancer.
Bian X; Dai H; Feng J; Ji H; Fang Y; Jiang N; Li W
Medicine (Baltimore); 2018 Jun; 97(22):e10988. PubMed ID: 29851855
[TBL] [Abstract][Full Text] [Related]
15. Rapid decline in visceral adipose tissue over 1 month is associated with poor prognosis in patients with unresectable pancreatic cancer.
Nakano O; Kawai H; Kobayashi T; Kohisa J; Ikarashi S; Hayashi K; Yokoyama J; Terai S
Cancer Med; 2021 Jul; 10(13):4291-4301. PubMed ID: 33993635
[TBL] [Abstract][Full Text] [Related]
16. Impact of Skeletal Muscle Mass Index, Intramuscular Adipose Tissue Content, and Visceral to Subcutaneous Adipose Tissue Area Ratio on Early Mortality of Living Donor Liver Transplantation.
Hamaguchi Y; Kaido T; Okumura S; Kobayashi A; Shirai H; Yagi S; Kamo N; Okajima H; Uemoto S
Transplantation; 2017 Mar; 101(3):565-574. PubMed ID: 27926595
[TBL] [Abstract][Full Text] [Related]
17. Detection of sarcopenic obesity and prediction of long-term survival in patients with gastric cancer using preoperative computed tomography and machine learning.
Kim J; Han SH; Kim HI
J Surg Oncol; 2021 Dec; 124(8):1347-1355. PubMed ID: 34490899
[TBL] [Abstract][Full Text] [Related]
18. Impact of body mass index and visceral adiposity on outcomes in colorectal cancer.
Yamamoto N; Fujii S; Sato T; Oshima T; Rino Y; Kunisaki C; Masuda M; Imada T
Asia Pac J Clin Oncol; 2012 Dec; 8(4):337-45. PubMed ID: 22897609
[TBL] [Abstract][Full Text] [Related]
19. Postoperative muscle mass restoration as a prognostic factor in patients with resected pancreatic cancer.
Lee J; Lee JC; Kim HW; Kim J; Hwang JH
PLoS One; 2020; 15(9):e0238649. PubMed ID: 32936836
[TBL] [Abstract][Full Text] [Related]
20. Impact of Sarcopenic Obesity on Outcomes in Patients Undergoing Hepatectomy for Hepatocellular Carcinoma.
Kobayashi A; Kaido T; Hamaguchi Y; Okumura S; Shirai H; Yao S; Kamo N; Yagi S; Taura K; Okajima H; Uemoto S
Ann Surg; 2019 May; 269(5):924-931. PubMed ID: 29064889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
